Prevalence of Physician-Reported Food Allergy in Canadian Children

Alexander G Singer1, Leanne Kosowan1, Lianne Soller2

  • 1Department of Family Medicine, University of Manitoba, Winnipeg, MB, Canada.

Insights

Physician-reported food allergy in Canadian children affects 2.53%, lower than self-reported rates. This study highlights associations with atopic conditions and psychiatric comorbidities.

Area of Science:

  • Pediatrics
  • Allergy and Immunology
  • Public Health Surveillance

Background:

  • Food allergy prevalence estimates vary widely, often relying on self-reported data.
  • Accurate prevalence data is crucial for public health planning and resource allocation.

Purpose of the Study:

  • To determine the prevalence of physician-diagnosed food allergy in Canadian children.
  • To utilize electronic medical record data for a more objective assessment of food allergy prevalence.

Main Methods:

  • Retrospective cohort study using the Canadian Primary Care Sentinel Surveillance Network (CPSSN) repository.
  • Application of machine learning algorithms to identify food allergy documentation within electronic medical records.
  • Analysis of demographic information, comorbidities, medications, and health behaviors.

Main Results:

  • The prevalence of physician-reported food allergy in Canadian children was 2.53%.
  • Peanut, tree nut, and cow's milk allergies were the most common.
  • Children with food allergy were more likely to have atopic comorbidities and psychiatric conditions (ADHD, autism, depression), and less likely to be obese.

Conclusions:

  • This study provides the first national estimate of physician-reported food allergy prevalence in Canadian children, showing a lower rate than self-reported estimates.
  • Further research is needed to explore the links between food allergy and psychiatric comorbidities, as well as obesity.
  • Findings underscore the importance of objective data sources for understanding food allergy epidemiology.
Abstract

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
31.5K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
147
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.2K
Taste Buds and Receptors01:20

Taste Buds and Receptors

Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...
4.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
111